Andrew J Sauer MD
@AndrewJSauer
Followers
19K
Following
25K
Media
1K
Statuses
19K
Cardiologist @MidAmericaHeart, building programs to implement therapies, advance discovery, and foster innovation for patients suffering from heart disease.
Kansas City, MO
Joined June 2014
My top ten tips for graduating fellows and faculty entering and continuing “early career” as I am transitioning into “mid-career”. A thread:.
94
438
2K
RT @drbennisahmed: Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialys….
0
3
0
RT @SeguraCardio: Honoured to be surrounded by such wonderful friends and "HF giants”, selected as the most impactful online Healthcare Pro….
0
7
0
RT @AndrewJSauer: For cardiologists out there are maintaining (MOC) for:. Internal Medicine .Cardiovascular Disease.AHFTC.
0
1
0
For cardiologists out there are maintaining (MOC) for:. Internal Medicine .Cardiovascular Disease.AHFTC.
0
1
6
RT @GiuseppeGalati_: 🔥 #HeartFailure attributed mortality in Europe, 2012–2021. Growing numbers of an epidemic that is now even more deadly….
0
20
0
RT @gcfmd: It has proved to be so very difficult to improve CV outcomes in patients receiving maintenance dialysis. Spironolactone versus p….
thelancet.com
Among patients receiving maintenance dialysis, spironolactone 25 mg daily orally did not reduce the composite outcome of cardiovascular mortality and hospitalisation due to heart failure compared...
0
8
0
RT @drbennisahmed: Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in HFpEF. In….
0
31
0
RT @drbennisahmed: Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRON….
0
5
0
RT @drbennisahmed: Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multi….
0
37
0
RT @MichaelAlbertMD: 🚨BREAKING: FDA grants accelerated approval to Wegovy (semaglutide 2.4 mg injection) for treating adults with non‑cirrh….
0
159
0
RT @EricTopol: Why does Zepbound (tirzepatide) lead to more weight loss than Ozempic (semaglutide)?.The dual receptor (GLP-1+ GIP) has mor….
0
167
0
RT @NEJM: MASLD has become the most common chronic liver disease worldwide. Giovanni Targher, MD, Luca Valenti, MD (@lucavalenti75), and Ch….
0
392
0
RT @EJHFEiC: Management of patients with heart failure at high risk of hyperkalaemia: The #CARE-HK in HF registry. @SJGreene_md .@AndrewJSa….
0
16
0
RT @SJGreene_md: 🚨 Now in @ESC_Journals #EJHF, primary results of the newest #HF registry. But this time, a special focus:.A dedicated, pro….
0
19
0
RT @DrMarthaGulati: When #HeartFailure meets #CVPrev & it becomes the center of everything we do, we can start saving hearts. Our joint @AS….
0
49
0
RT @HFSA: 📢 Just released! A new scientific statement from @HFSA and @ASPCardio, jointly published in @JCardFail and @AJPCardio places prev….
0
33
0
RT @AndrewJSauer: @SJGreene_md we report new RWE regarding patients w HF at risk for HK. CARE-HK in HF (n=2,558; 9 countries): . 29% had hy….
0
10
0
RT @drbennisahmed: Management of patients with heart failure at high risk of hyperkalaemia: The CARE-HK in HF registry. In this contemporar….
0
13
0
RT @HCPLiveNews: ICYMI: Finerenone (Kerendia) has received FDA approval for heart failure with EF >40%. Learn more about what this means i….
0
6
0